CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to treat cancer, today announced that recent in-vitro studies have confirmed that the Company’s technology could significantly reduce liver toxicity, a major problem with other cancer drugs
CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to treat cancer, today announced that Gordon Ringold, PhD, has joined the Company and will serve as Strategic Advisor
CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to treat cancer, today announced that it recently filed a foundational PCT patent application to protect its novel innovations
CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform designed to use the body’s immune system to treat cancer, today announced the release of a video presentation featuring its scientific team discussing the recent breakthrough
